34
Participants
Start Date
July 11, 2011
Primary Completion Date
April 27, 2015
Study Completion Date
April 27, 2015
AGS-22M6E
IV Infusion
ASG-22CE
IV Infusion
Memorial Sloan Kettering Cancer Center, New York
Roswell Park Cancer Institute, Buffalo
University of North Carolina, Chapel Hill, Chapel Hill
Emory University, Atlanta
Karmanos Cancer institute, Detroit
University of Colorado, Denver-Aurora, Aurora
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Dana-Farber Cancer Institute, Boston
Cross Cancer Institute, Edmonton
Lead Sponsor
Collaborators (1)
Agensys, Inc.
INDUSTRY
Seagen Inc.
INDUSTRY
Astellas Pharma Inc
INDUSTRY